Pediatric  ||| S:0 E:10 ||| FW
papillary  ||| S:10 E:20 ||| FW
thyroid  ||| S:20 E:28 ||| FW
carcinoma ||| S:28 E:37 ||| FW
:  ||| S:37 E:39 ||| :
outcomes  ||| S:39 E:48 ||| NNS
and  ||| S:48 E:52 ||| CC
survival  ||| S:52 E:61 ||| NN
predictors  ||| S:61 E:72 ||| NN
in  ||| S:72 E:75 ||| IN
2504  ||| S:75 E:80 ||| CD
surgical  ||| S:80 E:89 ||| JJ
patients  ||| S:89 E:98 ||| NNS
To  ||| S:98 E:101 ||| TO
evaluate  ||| S:101 E:110 ||| VB
outcomes  ||| S:110 E:119 ||| NNS
and  ||| S:119 E:123 ||| CC
predictors  ||| S:123 E:134 ||| NN
of  ||| S:134 E:137 ||| IN
survival  ||| S:137 E:146 ||| NN
of  ||| S:146 E:149 ||| IN
pediatric  ||| S:149 E:159 ||| JJ
thyroid  ||| S:159 E:167 ||| JJ
carcinoma ||| S:167 E:176 ||| NN
,  ||| S:176 E:178 ||| ,
specifically  ||| S:178 E:191 ||| RB
papillary  ||| S:191 E:201 ||| JJ
thyroid  ||| S:201 E:209 ||| JJ
carcinoma ||| S:209 E:218 ||| NN
.  ||| S:218 E:220 ||| .
SEER  ||| S:220 E:225 ||| NN
was  ||| S:225 E:229 ||| VBD
searched  ||| S:229 E:238 ||| VBN
for  ||| S:238 E:242 ||| IN
surgical  ||| S:242 E:251 ||| JJ
pediatric  ||| S:251 E:261 ||| JJ
cases  ||| S:261 E:267 ||| NNS
( ||| S:267 E:268 ||| -LRB-
≤20  ||| S:268 E:272 ||| CD
years  ||| S:272 E:278 ||| NNS
old ||| S:278 E:281 ||| JJ
)  ||| S:281 E:283 ||| -RRB-
of  ||| S:283 E:286 ||| IN
papillary  ||| S:286 E:296 ||| JJ
thyroid  ||| S:296 E:304 ||| NNS
carcinoma  ||| S:304 E:314 ||| VBP
diagnosed  ||| S:314 E:324 ||| VBN
between  ||| S:324 E:332 ||| IN
1973  ||| S:332 E:337 ||| CD
and  ||| S:337 E:341 ||| CC
2011 ||| S:341 E:345 ||| CD
.  ||| S:345 E:347 ||| .
Demographics ||| S:347 E:359 ||| NNS
,  ||| S:359 E:361 ||| ,
clinical  ||| S:361 E:370 ||| JJ
characteristics ||| S:370 E:385 ||| NNS
,  ||| S:385 E:387 ||| ,
and  ||| S:387 E:391 ||| CC
survival  ||| S:391 E:400 ||| NN
outcomes  ||| S:400 E:409 ||| NNS
were  ||| S:409 E:414 ||| VBD
analyzed  ||| S:414 E:423 ||| VBN
using  ||| S:423 E:429 ||| VBG
standard  ||| S:429 E:438 ||| JJ
statistical  ||| S:438 E:450 ||| JJ
methods ||| S:450 E:457 ||| NNS
.  ||| S:457 E:459 ||| .
All  ||| S:459 E:463 ||| DT
papillary  ||| S:463 E:473 ||| JJ
types ||| S:473 E:478 ||| NNS
,  ||| S:478 E:480 ||| ,
including  ||| S:480 E:490 ||| VBG
follicular  ||| S:490 E:501 ||| JJ
variant ||| S:501 E:508 ||| NN
,  ||| S:508 E:510 ||| ,
were  ||| S:510 E:515 ||| VBD
included ||| S:515 E:523 ||| VBN
.  ||| S:523 E:525 ||| .
A  ||| S:525 E:527 ||| DT
total  ||| S:527 E:533 ||| NN
of  ||| S:533 E:536 ||| IN
2504  ||| S:536 E:541 ||| CD
cases  ||| S:541 E:547 ||| NNS
were  ||| S:547 E:552 ||| VBD
identified ||| S:552 E:562 ||| VBN
.  ||| S:562 E:564 ||| .
Overall  ||| S:564 E:572 ||| JJ
incidence  ||| S:572 E:582 ||| NN
was  ||| S:582 E:586 ||| VBD
0.483 ||| S:586 E:591 ||| CD
/ ||| S:591 E:592 ||| CD
100,000  ||| S:592 E:600 ||| CD
persons  ||| S:600 E:608 ||| NNS
per  ||| S:608 E:612 ||| IN
year  ||| S:612 E:617 ||| NN
with  ||| S:617 E:622 ||| IN
a  ||| S:622 E:624 ||| DT
significant  ||| S:624 E:636 ||| JJ
annual  ||| S:636 E:643 ||| JJ
percent  ||| S:643 E:651 ||| NN
change  ||| S:651 E:658 ||| NN
( ||| S:658 E:659 ||| -LRB-
APC ||| S:659 E:662 ||| NNP
)  ||| S:662 E:664 ||| -RRB-
in  ||| S:664 E:667 ||| IN
occurrence  ||| S:667 E:678 ||| NN
of  ||| S:678 E:681 ||| IN
2.07  ||| S:681 E:686 ||| CD
%  ||| S:686 E:688 ||| NN
from  ||| S:688 E:693 ||| IN
baseline  ||| S:693 E:702 ||| NN
( ||| S:702 E:703 ||| -LRB-
P   ||| S:703 E:705 ||| NNP
< ||| S:705 E:706 ||| SYM
 0.05 ||| S:706 E:711 ||| NNP
) ||| S:711 E:712 ||| -RRB-
.  ||| S:712 E:714 ||| .
Mean  ||| S:714 E:719 ||| JJ
age  ||| S:719 E:723 ||| NN
at  ||| S:723 E:726 ||| IN
diagnosis  ||| S:726 E:736 ||| NN
was  ||| S:736 E:740 ||| VBD
16  ||| S:740 E:743 ||| CD
years  ||| S:743 E:749 ||| NNS
and  ||| S:749 E:753 ||| CC
highest  ||| S:753 E:761 ||| JJS
incidence  ||| S:761 E:771 ||| NN
was  ||| S:771 E:775 ||| VBD
found  ||| S:775 E:781 ||| VBN
in  ||| S:781 E:784 ||| IN
white ||| S:784 E:789 ||| JJ
,  ||| S:789 E:791 ||| ,
female  ||| S:791 E:798 ||| JJ
patients  ||| S:798 E:807 ||| NNS
ages  ||| S:807 E:812 ||| VBD
15-19 ||| S:812 E:817 ||| CD
.  ||| S:817 E:819 ||| .
Patients  ||| S:819 E:828 ||| NNS
with  ||| S:828 E:833 ||| IN
tumor  ||| S:833 E:839 ||| CD
sizes   ||| S:839 E:845 ||| CD
< ||| S:845 E:846 ||| SYM
1 cm  ||| S:846 E:851 ||| CD
more  ||| S:851 E:856 ||| JJR
likely  ||| S:856 E:863 ||| JJ
received  ||| S:863 E:872 ||| FW
lobectomies ||| S:872 E:883 ||| FW
/ ||| S:883 E:884 ||| FW
isthmusectomies  ||| S:884 E:900 ||| FW
versus  ||| S:900 E:907 ||| FW
subtotal ||| S:907 E:915 ||| FW
/ ||| S:915 E:916 ||| FW
total  ||| S:916 E:922 ||| FW
thyroidectomies  ||| S:922 E:938 ||| FW
[ ||| S:938 E:939 ||| -LRB-
OR = 3.03  ||| S:939 E:949 ||| NNP
( ||| S:949 E:950 ||| -LRB-
2.12 ||| S:950 E:954 ||| CD
,  ||| S:954 E:956 ||| ,
4.32 ||| S:956 E:960 ||| CD
) ||| S:960 E:961 ||| -RRB-
;  ||| S:961 E:963 ||| :
P   ||| S:963 E:965 ||| CD
< ||| S:965 E:966 ||| SYM
 0.001 ||| S:966 E:972 ||| CD
] ||| S:972 E:973 ||| -RRB-
.  ||| S:973 E:975 ||| .
Patients  ||| S:975 E:984 ||| NNS
with  ||| S:984 E:989 ||| IN
tumors ≥1 cm  ||| S:989 E:1002 ||| NNP
and  ||| S:1002 E:1006 ||| CC
lymph  ||| S:1006 E:1012 ||| JJ
node-positive  ||| S:1012 E:1026 ||| JJ
statuses  ||| S:1026 E:1035 ||| NNS
[ ||| S:1035 E:1036 ||| -LRB-
OR = 99.0  ||| S:1036 E:1046 ||| NNP
( ||| S:1046 E:1047 ||| -LRB-
12.5 ||| S:1047 E:1051 ||| CD
,  ||| S:1051 E:1053 ||| ,
783 ||| S:1053 E:1056 ||| CD
) ||| S:1056 E:1057 ||| -RRB-
;  ||| S:1057 E:1059 ||| :
P   ||| S:1059 E:1061 ||| CD
< ||| S:1061 E:1062 ||| SYM
 0.001 ||| S:1062 E:1068 ||| CD
]  ||| S:1068 E:1070 ||| -RRB-
more  ||| S:1070 E:1075 ||| JJR
likely  ||| S:1075 E:1082 ||| JJ
underwent  ||| S:1082 E:1092 ||| NN
subtotal ||| S:1092 E:1100 ||| VBD
/ ||| S:1100 E:1101 ||| CD
total  ||| S:1101 E:1107 ||| NN
thyroidectomy  ||| S:1107 E:1121 ||| VBZ
compared  ||| S:1121 E:1130 ||| VBN
to  ||| S:1130 E:1133 ||| TO
lobectomy ||| S:1133 E:1142 ||| CD
/ ||| S:1142 E:1143 ||| CD
isthmusectomy ||| S:1143 E:1156 ||| NNS
.  ||| S:1156 E:1158 ||| .
Tumors ≥1 cm  ||| S:1158 E:1171 ||| NNP
were  ||| S:1171 E:1176 ||| VBD
more  ||| S:1176 E:1181 ||| RBR
likely  ||| S:1181 E:1188 ||| JJ
lymph  ||| S:1188 E:1194 ||| NN
node-positive  ||| S:1194 E:1208 ||| NNS
[ ||| S:1208 E:1209 ||| -LRB-
OR = 39.4  ||| S:1209 E:1219 ||| NNP
( ||| S:1219 E:1220 ||| -LRB-
16.6 ||| S:1220 E:1224 ||| CD
,  ||| S:1224 E:1226 ||| ,
93.7 ||| S:1226 E:1230 ||| CD
) ||| S:1230 E:1231 ||| -RRB-
;  ||| S:1231 E:1233 ||| :
p   ||| S:1233 E:1235 ||| CD
< ||| S:1235 E:1236 ||| SYM
 0.001 ||| S:1236 E:1242 ||| CD
] ||| S:1242 E:1243 ||| -RRB-
.  ||| S:1243 E:1245 ||| .
Mortality  ||| S:1245 E:1255 ||| NN
did  ||| S:1255 E:1259 ||| VBD
not  ||| S:1259 E:1263 ||| RB
differ  ||| S:1263 E:1270 ||| VB
between  ||| S:1270 E:1278 ||| IN
procedures ||| S:1278 E:1288 ||| NNS
.  ||| S:1288 E:1290 ||| .
Mean  ||| S:1290 E:1295 ||| JJ
survival  ||| S:1295 E:1304 ||| NN
was  ||| S:1304 E:1308 ||| VBD
38.6 years  ||| S:1308 E:1319 ||| CD
and  ||| S:1319 E:1323 ||| CC
higher  ||| S:1323 E:1330 ||| JJR
in  ||| S:1330 E:1333 ||| IN
those  ||| S:1333 E:1339 ||| DT
with  ||| S:1339 E:1344 ||| IN
regional  ||| S:1344 E:1353 ||| JJ
disease ||| S:1353 E:1360 ||| NN
.  ||| S:1360 E:1362 ||| .
Disease-specific  ||| S:1362 E:1379 ||| JJ
30-year  ||| S:1379 E:1387 ||| JJ
survival  ||| S:1387 E:1396 ||| NN
ranged  ||| S:1396 E:1403 ||| VBD
from  ||| S:1403 E:1408 ||| IN
99  ||| S:1408 E:1411 ||| CD
to  ||| S:1411 E:1414 ||| TO
100  ||| S:1414 E:1418 ||| CD
% ||| S:1418 E:1419 ||| NN
,  ||| S:1419 E:1421 ||| ,
regardless  ||| S:1421 E:1432 ||| RB
of  ||| S:1432 E:1435 ||| IN
tumor  ||| S:1435 E:1441 ||| NN
size  ||| S:1441 E:1446 ||| NN
or  ||| S:1446 E:1449 ||| CC
procedure ||| S:1449 E:1458 ||| NN
.  ||| S:1458 E:1460 ||| .
Lymph  ||| S:1460 E:1466 ||| JJ
node  ||| S:1466 E:1471 ||| JJ
sampling  ||| S:1471 E:1480 ||| NN
did  ||| S:1480 E:1484 ||| VBD
not  ||| S:1484 E:1488 ||| RB
affect  ||| S:1488 E:1495 ||| VB
survival ||| S:1495 E:1503 ||| NN
.  ||| S:1503 E:1505 ||| .
The  ||| S:1505 E:1509 ||| DT
incidence  ||| S:1509 E:1519 ||| NN
of  ||| S:1519 E:1522 ||| IN
pediatric  ||| S:1522 E:1532 ||| JJ
papillary  ||| S:1532 E:1542 ||| JJ
thyroid  ||| S:1542 E:1550 ||| JJ
cancer  ||| S:1550 E:1557 ||| NN
is  ||| S:1557 E:1560 ||| VBZ
increasing ||| S:1560 E:1570 ||| VBG
.  ||| S:1570 E:1572 ||| .
Females  ||| S:1572 E:1580 ||| NNS
have  ||| S:1580 E:1585 ||| VBP
a  ||| S:1585 E:1587 ||| DT
higher  ||| S:1587 E:1594 ||| JJR
incidence ||| S:1594 E:1603 ||| NN
,  ||| S:1603 E:1605 ||| ,
but  ||| S:1605 E:1609 ||| CC
similar  ||| S:1609 E:1617 ||| JJ
survival  ||| S:1617 E:1626 ||| NN
to  ||| S:1626 E:1629 ||| TO
males ||| S:1629 E:1634 ||| NNS
.  ||| S:1634 E:1636 ||| .
Tumors  ||| S:1636 E:1643 ||| NNP
≥1 cm  ||| S:1643 E:1649 ||| NNP
were  ||| S:1649 E:1654 ||| VBD
likely  ||| S:1654 E:1661 ||| JJ
to  ||| S:1661 E:1664 ||| TO
be  ||| S:1664 E:1667 ||| VB
lymph  ||| S:1667 E:1673 ||| JJ
node-positive ||| S:1673 E:1686 ||| NN
.  ||| S:1686 E:1688 ||| .
Although  ||| S:1688 E:1697 ||| IN
tumors  ||| S:1697 E:1704 ||| JJ
≥1 cm  ||| S:1704 E:1710 ||| NN
were  ||| S:1710 E:1715 ||| VBD
more  ||| S:1715 E:1720 ||| RBR
likely  ||| S:1720 E:1727 ||| JJ
to  ||| S:1727 E:1730 ||| TO
be  ||| S:1730 E:1733 ||| VB
resected  ||| S:1733 E:1742 ||| VBN
by  ||| S:1742 E:1745 ||| IN
subtotal ||| S:1745 E:1753 ||| CD
/ ||| S:1753 E:1754 ||| CD
total  ||| S:1754 E:1760 ||| JJ
thyroidectomy ||| S:1760 E:1773 ||| NN
,  ||| S:1773 E:1775 ||| ,
survival  ||| S:1775 E:1784 ||| NN
was  ||| S:1784 E:1788 ||| VBD
high  ||| S:1788 E:1793 ||| JJ
and  ||| S:1793 E:1797 ||| CC
did  ||| S:1797 E:1801 ||| VBD
not  ||| S:1801 E:1805 ||| RB
differ  ||| S:1805 E:1812 ||| VBP
based  ||| S:1812 E:1818 ||| VBN
on  ||| S:1818 E:1821 ||| IN
procedure ||| S:1821 E:1830 ||| NN
.  ||| S:1830 E:1832 ||| .
